Connected data gives you a clearer picture
At Evaluate we collect, calibrate and connect the pharmaceutical world's data.
Thought Leadership
Latest Report
How to spot blockbuster potential?
In 2021, the pharma industry invested over $600 billion in R&D, M&A and licensing in search of the next life-changing and market-leading products. With a patent cliff in 2028 looming, the race is on to identify the assets that will drive the next wave of success. But there’s a problem. Our analysis found that just 20% of marketed drugs…
Report library
Pharma Market Drivers Part Three: Blowin’ in the wind
There are some things in life you want to be consistent and predictable. Interest rates. Train timetables. The weather. And if you work in the pharma industry, the…
Q3 Round Up: Alive but not kicking report
What happened in Q3? Did the glimmers of light we saw at the start of the quarter really come to anything or were they a false dawn? In this eBook, we investigate whether…
Q3 Round up: Alive but not kicking infographic
In this quarterly snapshot, we highlight financial and business trends in biopharma. Download our Q3 Roundup infographic now for our quick take on M&A activity, the…
Intelligent forecasting for pharmaceutical R&D
Commercial analytics and forecasting underpin strategic decision-making and business planning across the pharmaceutical and life science sectors. Inaccurate risk…
The Impact of Data Science
Digital technologies have plenty to offer a pharma industry seeking to up its productivity game. Attention often focuses artificial intelligence powered drug discovery or…
World Preview 2022: Outlook to 2028 Report
After a 27-month rollercoaster ride, can we expect a return to normal? Battered biotech is reviving after booming and busting in spectacular fashion. M&A is…
World Preview: Patents and Pricing Infographic
Our annual World Preview infographic provides forward-looking analysis of the pharma and biotech market, based on Evaluate consensus forecasts to 2028. The top…
ESMO 2022 eBook
The European Society of Medical Oncology Conference (ESMO) in Paris has wrapped up and there was much to talk about as Europe’s top oncologists came together to announce…
Medtech World Preview 2022: Back to Reality Report
Amid the challenges of a global pandemic, parts of the medtech sector were positioned to reap some of the spoils enjoyed by the big pharma players. Huge demand for Covid…
Medtech World Preview 2022: Back to Reality Infographic
Amid the challenges of a global pandemic, parts of the medtech sector were positioned to reap some of the spoils enjoyed by the big pharma players. As the pandemic…
